Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores
DNA gyrase is an important target for the development of novel antibiotics. Although ATP-competitive DNA gyrase (GyrB) inhibitors are a well-studied class of antibacterial agents, there is currently no representative used in therapy, largely due to unwanted off-target activities. Selectivity of GyrB...
Saved in:
Main Authors: | Tihomir Tomašič (Author), Asta Zubrienė (Author), Žiga Skok (Author), Riccardo Martini (Author), Stane Pajk (Author), Izidor Sosič (Author), Janez Ilaš (Author), Daumantas Matulis (Author), Sharon D. Bryant (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation
by: Martina Durcik, et al.
Published: (2020) -
Identification of novel bacterial DNA gyrase inhibitors: An in silico study
by: Hamzeh Rahimi, et al.
Published: (2016) -
Oxidation of Drugs during Drug Product Development: Problems and Solutions
by: Alen Gabrič, et al.
Published: (2022) -
In Silico Study of the Potential Inhibitory Effects on <i>Escherichia coli</i> DNA Gyrase of Some Hypothetical Fluoroquinolone-Tetracycline Hybrids
by: Ioana-Andreea Lungu, et al.
Published: (2024) -
Exploring the Antimicrobial and Pharmacological Potential of NF22 as a Potent Inhibitor of <i>E. coli</i> DNA Gyrase: An In Vitro and In Silico Study
by: Samman Munir, et al.
Published: (2022)